On Dec 20, 2021 VBL THERAPEUTICS closed a Post-IPO Equity round and raised €15,000,000 from European Innovation Council, featuring lead investors European Innovation Council. About […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Grant – VBL THERAPEUTICS
On Dec 20, 2021 VBL THERAPEUTICS closed a Grant round and raised €2,500,000 from European Innovation Council, featuring lead investors European Innovation Council. About the […]
Startup Interview – Genz Biotechnology
As part of the startup Interview series, we are going to interview Mr. Umut Ağyüz from GENZ Biotechnology, a London-headquartered spin-off BioTech company developing novel solutions from in […]
Series A – Mana Therapeutics
On Nov 30, 2021 Mana Therapeutics closed a Series A round and raised $7,000,000 from J&W Partners and SK Securities. About the company: Mana Therapeutics […]
Debt Financing – Mana Therapeutics
On Nov 30, 2021 Mana Therapeutics closed a Debt Financing round and raised $7,500,000 from Silicon Valley Bank, featuring lead investors Silicon Valley Bank. About […]
Dicerna Pharmaceuticals acquired by Novo Nordisk
Nov 18, 2021 Novo Nordisk has entered into an agreement to acquire Dicerna Pharmaceuticals in a $3,300,000,000 deal. Novo Nordisk based at Bagsværd, Hovedstaden, Denmark. […]
Post-IPO Debt – BridgeBio Pharma
On Nov 18, 2021 BridgeBio Pharma closed a Post-IPO Debt round and raised $750,000,000 from investors, featuring lead investors . About the company: BridgeBio Pharma […]
Series B – Tavotek Biotherapeutics
On Nov 18, 2021 Tavotek Biotherapeutics closed a Series B round and raised $35,000,000 from CS Capital, Fontus Capital, featuring lead investors CS Capital. About […]
Series B – Treadwell Therapeutics
On Nov 18, 2021 Treadwell Therapeutics closed a Series B round and raised $91,000,000 from 3W Fund Management, Adrian Cheng, Alpha Win Capital, Fortune Ocean […]
